BIOX Stock Analysis: Buy, Sell, or Hold?
BIOX - Bioceres Crop Solutions Corp. Ordinary Shares
$0.44
-0.01 (-2.00%)
▼
5d:
-1.8%
30d:
+26.7%
90d:
+1.36%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Sep 08, 2026
14d
Get Alerted When BIOX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BIOX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BIOX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: BIOX is currently trading at $0.44, which is considered extended relative to its 30-day fair value range of $0.33 to $0.41. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.8) compared to its historical average (11.0). Remarkably, the market is currently pricing in an annual earnings decline of 7.2% over the next few years. This pessimistic expectation contrasts with the company's recent 34.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BIOX is in a strong downtrend. Immediate support is located at $0.33, while resistance sits at $0.48.
Market Sentiment: BIOX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.00 (+353.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BIOX is in a strong downtrend. Immediate support is located at $0.33, while resistance sits at $0.48.
Market Sentiment: BIOX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.00 (+353.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.33 -
$0.41
Company Quality Score
25/100
(STRONG SELL)
Volume Confirmation
HIGH
Confidence Score
23.8%
All Signals
- BEARISH: Price extended above range (+7.5% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 353.6% below Wall St target ($2.00)
- WARNING: Composite score 25/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.33 -
$0.41
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.33
Resistance Level
$0.48
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.82
Wall Street Target
$2.00
(+353.6%)
Revenue Growth (YoY)
-35.9%
Earnings Growth (YoY)
34.4%
Profit Margin
-96.9%
Valuation Discount vs History
-7.2% cheaper
PE vs Historical
8.8 vs 11.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.2%
(market-implied from PE analysis)
1-Year Target
$0.41
(-7%)
2-Year Target
$0.38
(-14%)
3-Year Target
$0.35
(-20%)
3-Yr Target (if PE normalizes)
(PE: 9→11)
$0.44
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.8 to 11.0
Stabilization Target:
$0.55
(+24.7%)
PE Expansion Potential:
+24.7%
Share & Embed Analysis
Last updated: August 24, 2026 12:11 AM ET
Data refreshes hourly during market hours. Next update: 1:11 AM
Data refreshes hourly during market hours. Next update: 1:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIOX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Agricultural Inputs Stocks
Top-rated stocks in Agricultural Inputs by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CTVA
Corteva Inc |
STRONG BUY
24 analysts |
$92 | 50 HOLD |
|
NTR
Nutrien Ltd |
STRONG BUY
24 analysts |
$76 | 34 SELL |
|
MOS
The Mosaic Company |
BUY
20 analysts |
$26 | 36 SELL |
|
SMG
Scotts Miracle-Gro Compa… |
STRONG BUY
11 analysts |
$77 | 64 BUY |
|
FMC
FMC Corporation |
HOLD
20 analysts |
$14 | 43 HOLD |
